Literature DB >> 10828050

Independent formation of DnaseI hypersensitive sites in the murine beta-globin locus control region.

M A Bender1, M G Mehaffey, A Telling, B Hug, T J Ley, M Groudine, S Fiering.   

Abstract

Mammalian beta-globin loci are composed of multiple orthologous genes whose expression is erythroid specific and developmentally regulated. The expression of these genes both from the endogenous locus and from transgenes is strongly influenced by a linked 15-kilobase region of clustered DNaseI hypersensitive sites (HSs) known as the locus control region (LCR). The LCR encompasses 5 major HSs, each of which is highly homologous among humans, mice, and other mammals. To analyze the function of individual HSs in the endogenous murine beta-globin LCR, we have used homologous recombination in embryonic stem cells to produce 5 mouse lines, each of which is deficient for 1 of these major HSs. In this report, we demonstrate that deletion of the conserved region of 5'HS 1, 2, 3, 4, or 5/6 abolishes HS formation at the deletion site but has no influence on the formation of the remaining HSs in the LCR. Therefore, in the endogenous murine locus, there is no dominant or initiating site whose formation must precede the formation of the other HSs. This is consistent with the idea that HSs form autonomously. We discuss the implications of these findings for current models of beta-globin regulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10828050

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  18 in total

Review 1.  Locus control regions.

Authors:  Qiliang Li; Kenneth R Peterson; Xiangdong Fang; George Stamatoyannopoulos
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

Review 2.  The regulatory network controlling beta-globin gene switching.

Authors:  W Shen; D P Liu; C C Liang
Journal:  Mol Biol Rep       Date:  2001       Impact factor: 2.316

3.  Chromosomal elements regulate gene activity and chromatin structure of the human serpin gene cluster at 14q32.1.

Authors:  Mark D Marsden; R E K Fournier
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

4.  Synergistic and additive properties of the beta-globin locus control region (LCR) revealed by 5'HS3 deletion mutations: implication for LCR chromatin architecture.

Authors:  Xiangdong Fang; Jin Sun; Ping Xiang; Man Yu; Patrick A Navas; Kenneth R Peterson; George Stamatoyannopoulos; Qiliang Li
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

Review 5.  Transcriptional mechanisms underlying hemoglobin synthesis.

Authors:  Koichi R Katsumura; Andrew W DeVilbiss; Nathaniel J Pope; Kirby D Johnson; Emery H Bresnick
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

6.  H3 K79 dimethylation marks developmental activation of the beta-globin gene but is reduced upon LCR-mediated high-level transcription.

Authors:  Tomoyuki Sawado; Jessica Halow; Hogune Im; Tobias Ragoczy; Emery H Bresnick; M A Bender; Mark Groudine
Journal:  Blood       Date:  2008-04-25       Impact factor: 22.113

7.  Deletion of the core region of 5' HS2 of the mouse beta-globin locus control region reveals a distinct effect in comparison with human beta-globin transgenes.

Authors:  Xiao Hu; Michael Bulger; M A Bender; Jennifer Fields; Mark Groudine; Steven Fiering
Journal:  Blood       Date:  2005-09-27       Impact factor: 22.113

Review 8.  Evolution of hemoglobin loci and their regulatory elements.

Authors:  Sjaak Philipsen; Ross C Hardison
Journal:  Blood Cells Mol Dis       Date:  2017-08-09       Impact factor: 3.039

9.  Differential requirement of a distal regulatory region for pre-initiation complex formation at globin gene promoters.

Authors:  Julie Ross; Stefania Bottardi; Vincent Bourgoin; Alex Wollenschlaeger; Elliot Drobetsky; Marie Trudel; Eric Milot
Journal:  Nucleic Acids Res       Date:  2009-06-30       Impact factor: 16.971

10.  Evolution of hemoglobin and its genes.

Authors:  Ross C Hardison
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.